Glioblastoma multiformes (GBMs) are primary brain tumors displaying invasive growth properties that are tightly coupled to the vasculature. For example, stem-like GBM cells preferentially cluster in perivascular niches and invasive GBM cells often disperse throughout the brain via vascular basement membranes. Furthermore, anti-angiogenesis therapies administered to patients with GBM often lead to enhanced tumor cell infiltration and the formation of lethal satellite lesions. The molecular mechanisms that couple GBM cells to cerebral blood vessels during tumor progression and following anti-angiogenesis therapies remain largely unknown. In this project we will investigate how GBM cells exploit a specific cell adhesion and signaling axis comprised of ?v?8 integrin, its latent TGF? extracellular matrix (ECM) protein ligands, and TGF? receptors to selectively promote perivascular growth and dispersal in the brain. We have discovered that ?v?8 integrin is expressed in invasive GBM cells where it mediates activation of TGF?s to drive cell polarity and directional migration. In addition, ?v?8 integrin protein is highly expressed in invasive GBM cells following anti-angiogenesis treatments. Based on these data we hypothesize that ?v?8 integrin regulates adhesion and signaling pathways that promote GBM cell invasion during tumor progression and following anti-vascular therapies. Furthermore, we hypothesize that inhibiting components of these pathways will diminish GBM cell infiltration. To test our hypotheses we have developed a unique set of experimental tools to (1) characterize how ?v?8 integrin interacts with the VEGF-A receptor Neuropilin-1 to promote GBM cell infiltration;(2) investigate how integrin-activated TGF?s cooperate with VEGF-A to drive GBM cell invasiveness;and (3) selectively inhibit components of these pathways to block invasiveness in pre-clinical mouse models of GBM. Collectively, these experiments will not only elucidate novel links between ?v?8 integrin-activated TGF?s and VEGF-A receptors in GBM cells, but may eventually lead to new therapeutic strategies for inhibiting cell invasion during tumor progression and following anti-vascular therapies.

Public Health Relevance

Glioblastomas are incurable brain tumors with highly invasive growth properties. In this project we will characterize how adhesion proteins known as integrins and their extracellular matrix ligands drive glioblastoma invasive growth. Characterizing these pathways will be an important first step toward designing new therapies to target invasive cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS078402-03
Application #
8668175
Study Section
Tumor Microenvironment Study Section (TME)
Program Officer
Fountain, Jane W
Project Start
2012-09-15
Project End
2017-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
3
Fiscal Year
2014
Total Cost
$380,601
Indirect Cost
$139,714
Name
University of Texas MD Anderson Cancer Center
Department
Biology
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Reyes, Steve B; Narayanan, Anjana S; Lee, Hye Shin et al. (2013) *v*8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion. Mol Biol Cell 24:474-82
McCarty, Joseph H (2013) Glioblastoma resistance to anti-VEGF therapy: has the challenge been MET? Clin Cancer Res 19:1631-3